Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PDZ domain-containing protein 11 pseudogene (ENSG00000259079) is categorized as a pseudogene, meaning it is a segment of DNA similar to a known gene but is generally nonfunctional due to mutations that prevent its transcription or translation into a functional protein. Pseudogenes arise through gene duplication or retrotransposition events and typically do not encode proteins, though in some instances, they may be transcribed and exert gene regulatory effects. There is no evidence that this pseudogene encodes a protein or serves as a therapeutic target in any known disease context. It should not be confused with the protein-coding gene “PDZ domain-containing protein 11” (PDZD11, ENSG00000120509).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ domain-containing protein 11 pseudogene.